Stay updated on Epacadostat + Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.

Latest updates to the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded a consolidated Locations section listing study sites (California, Colorado, Florida, Illinois, Kentucky, North Carolina, and Texas) and removed the previous per-state location subsections. Updated the page revision note to v3.3.3.SummaryDifference0.8%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe Publications section wording was updated to say publications are automatically filled from PubMed, replacing the previous phrasing. The revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check44 days agoChange DetectedThe government funding status banner was removed from the page. Core study details and links remain unchanged.SummaryDifference0.4%

- Check58 days agoChange DetectedNo additions or deletions were detected; the page content and structure appear unchanged.SummaryDifference0.4%

- Check87 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference4%

- Check94 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Epacadostat + Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.